RETINAL DEGENERATION

Clinical trials for RETINAL DEGENERATION explained in plain language.

Never miss a new study

Get alerted when new RETINAL DEGENERATION trials appear

Sign up with your email to follow new studies for RETINAL DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 2 Not yet finished but already full! 2 Completed 1 Terminated 1

New eye injection shows promise for rare Blindness-Causing condition

Disease control Completed

This early-stage study tested the safety of a new medicine called VP-001, given as an injection into the eye, for people with a rare inherited retinal disease caused by a PRPF31 gene mutation. Six participants received multiple doses to see if the treatment was safe and tolerable…

Matched conditions: RETINAL DEGENERATION

Phase: PHASE1 • Sponsor: PYC Therapeutics • Aim: Disease control

Last updated May 15, 2026 11:53 UTC

RETINAL DEGENERATION

Get alerted when new RETINAL DEGENERATION trials appear

New eye injection shows promise for rare Blindness-Causing condition